By Jeff Montgomery ( May 6, 2016, 9:21 PM EDT) -- KaloBios Pharmaceuticals, formerly helmed by indicted CEO Martin Shkreli, won approval for its Chapter 11 disclosure and schedule Friday, after approval of a settlement with prepetition equity buyers and the temporary sidelining of recovery efforts by a former director who also invested days before the company's collapse....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.